Consolidated Statement of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Net interest income
Interest income	$ 35,366	$ 37,491	$ 104,305	$ 110,630
Interest expense	20,133	23,524	59,959	68,929
Net interest income	15,233	13,967	44,346	41,701
Noninterest income
Fees and commissions	10,337	9,119	29,221	26,748
Market making and similar activities	3,203	3,278	9,940	10,464
Other income (loss)	(685)	(1,019)	(1,590)	(2,373)
Total noninterest income	12,855	11,378	37,571	34,839
Total revenue, net of interest expense	28,088	25,345	81,917	76,540
Provision for credit losses	1,295	1,542	4,367	4,369
Noninterest expense
Compensation and benefits	10,523	9,916	31,744	29,937
Occupancy and equipment	1,872	1,836	5,564	5,465
Information processing and communications	1,827	1,784	5,540	5,347
Product delivery and transaction related	1,025	849	2,913	2,591
Professional fees	606	723	1,898	1,925
Marketing	572	504	1,641	1,446
Other general operating	912	867	2,990	3,314
Total noninterest expense	17,337	16,479	52,290	50,025
Income before income taxes	9,456	7,324	25,260	22,146
Income tax expense	987	428	2,279	1,679
Net income	8,469	6,896	22,981	20,467
Preferred stock dividends and other	429	516	1,126	1,363
Net income applicable to common shareholders	$ 8,040	$ 6,380	$ 21,855	$ 19,104
Per common share information
Earnings (in dollars per share)	$ 1.08	$ 0.82	$ 2.89	$ 2.42
Diluted earnings (in dollars per share)	$ 1.06	$ 0.81	$ 2.85	$ 2.40
Average common shares issued and outstanding (in shares)	7,466.0	7,818.0	7,574.5	7,894.7
Average diluted common shares issued and outstanding (in shares)	7,627.1	7,902.1	7,724.7	7,965.0

Consolidated Statement of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities
Net income	$ 22,981	$ 20,467
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	4,367	4,369
Losses on sales of debt securities	23	6
Depreciation and amortization	1,720	1,630
Net accretion of discount/premium on debt securities	(664)	(354)
Deferred income taxes	(255)	(1,228)
Amortization of stock-based compensation	3,032	2,542
Net change in:
Trading and derivative assets/liabilities	4,687	(56,685)
Loans held-for-sale	2,672	(4,633)
Other assets	(24,543)	(20,257)
Accrued expenses and other liabilities	20,239	14,581
Other operating activities, net	1,299	4,843
Net cash provided by (used in) operating activities	35,558	(34,719)
Investing activities
Time deposits placed and other short-term investments	(1,840)	195
Federal funds sold and securities borrowed or purchased under agreements to resell	(55,078)	(54,582)
Debt securities carried at fair value:
Proceeds from sales	96,786	52,594
Proceeds from paydowns and maturities	63,781	217,602
Purchases	(196,704)	(312,186)
Held-to-maturity debt securities:
Proceeds from paydowns and maturities	26,327	26,033
Loans and leases:
Proceeds from sales of loans originally classified as held for investment and instruments from related securitization activities	6,718	7,129
Purchases	(12,487)	(4,151)
Other changes in loans and leases, net	(68,672)	(29,874)
Other investing activities, net	(2,816)	(2,863)
Net cash used in investing activities	(143,985)	(100,103)
Financing activities
Deposits	36,741	6,525
Federal funds purchased and securities loaned or sold under agreements to repurchase	14,817	114,071
Short-term borrowings	10,802	7,623
Long-term debt:
Proceeds from issuance	75,855	42,593
Retirement	(57,893)	(52,711)
Preferred stock:
Proceeds from issuance	5,493	0
Redemption	(2,669)	(3,854)
Common stock repurchased	(15,123)	(9,569)
Cash dividends paid	(7,203)	(7,228)
Other financing activities, net	(919)	(313)
Net cash provided by financing activities	59,901	97,137
Effect of exchange rate changes on cash and cash equivalents	4,919	201
Net decrease in cash and cash equivalents	(43,607)	(37,484)
Cash and cash equivalents at January 1	290,114	333,073
Cash and cash equivalents at September 30	$ 246,507	$ 295,589

Consolidated Balance Sheet - USD ($) $ in Millions	Sep. 30, 2025	Dec. 31, 2024
Assets
Cash and due from banks	$ 25,352	$ 26,003
Interest-bearing deposits with the Federal Reserve, non-U.S. central banks and other banks	221,155	264,111
Cash and cash equivalents	246,507	290,114
Time deposits placed and other short-term investments	8,212	6,372
Federal funds sold and securities borrowed or purchased under agreements to resell (includes $173,686 and $144,501 measured at fair value)	325,800	274,709
Trading account assets (includes $174,783 and $170,328 pledged as collateral)	335,566	314,460
Derivative assets	42,115	40,948
Debt securities:
Carried at fair value	404,636	358,607
Held-to-maturity, at cost (fair value $446,544 and $450,548)	531,414	558,677
Total debt securities	936,050	917,284
Loans and leases (includes $6,694 and $4,249 measured at fair value)	1,165,900	1,095,835
Allowance for loan and lease losses	(13,252)	(13,240)
Loans and leases, net of allowance	1,152,648	1,082,595
Premises and equipment, net	12,348	12,168
Goodwill	69,021	69,021
Loans held-for-sale (includes $2,071 and $2,214 measured at fair value)	6,831	9,545
Customer and other receivables	99,863	82,247
Other assets (includes $9,830 and $13,176 measured at fair value)	168,755	162,056
Total assets	3,403,716	3,261,519
Deposits in U.S. offices:
Noninterest-bearing	510,208	507,561
Interest-bearing (includes $1,079 and $310 measured at fair value)	1,354,445	1,329,014
Deposits in non-U.S. offices:
Noninterest-bearing	14,690	16,297
Interest-bearing	122,865	112,595
Total deposits	2,002,208	1,965,467
Federal funds purchased and securities loaned or sold under agreements to repurchase (includes $215,376 and $192,859 measured at fair value)	342,588	331,758
Trading account liabilities	117,322	92,543
Derivative liabilities	40,157	39,353
Short-term borrowings (includes $6,432 and $6,245 measured at fair value)	54,200	43,391
Accrued expenses and other liabilities (includes $8,511 and $13,199 measured at fair value and $1,109 and $1,096 of reserve for unfunded lending commitments)	231,605	210,169
Long-term debt (includes $66,315 and $50,005 measured at fair value)	311,484	283,279
Total liabilities	3,099,564	2,965,960
Commitments and contingencies (Note 6 – Securitizations and Other Variable Interest Entities and Note 10 – Commitments and Contingencies)
Shareholders’ equity
Preferred stock, $0.01 par value; authorized – 100,000,000 shares; issued and outstanding – 3,991,164 and 3,877,917 shares	25,992	23,159
Common stock and additional paid-in capital, $0.01 par value; authorized – 12,800,000,000 shares; issued and outstanding – 7,329,421,929 and 7,610,862,311 shares	31,764	45,336
Retained earnings	258,141	242,349
Accumulated other comprehensive income (loss)	(11,745)	(15,285)
Total shareholders’ equity	304,152	295,559
Total liabilities and shareholders’ equity	3,403,716	3,261,519
Consolidated VIEs
Assets
Trading account assets (includes $174,783 and $170,328 pledged as collateral)	6,063	5,575
Debt securities:
Loans and leases (includes $6,694 and $4,249 measured at fair value)	18,007	19,144
Allowance for loan and lease losses	(889)	(919)
Loans and leases, net of allowance	17,118	18,225
Other assets (includes $9,830 and $13,176 measured at fair value)	614	319
Total assets	23,795	24,119
Deposits in non-U.S. offices:
Short-term borrowings (includes $6,432 and $6,245 measured at fair value)	4,980	3,329
Long-term debt (includes $66,315 and $50,005 measured at fair value)	8,420	8,457
All other liabilities (includes $22 and $21 of non-recourse liabilities)	22	21
Total liabilities	$ 13,422	$ 11,807